Emergent resistance to antiretroviral (ARV) agents used in optimized background therapy (OBT) with fostemsavir (FTR): week 96 results of the phase 3 BRIGHTE study in heavily treatment-experienced (HTE) adults living with multidrug-resistant (MDR) HIV-1
HIV MEDICINE（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要